Journal articles on the topic 'Therapeutic modality for cancer'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Therapeutic modality for cancer.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Agarwal, Shashi K. "Exercise: Preventive and Therapeutic Benefits in Cancer." Journal of Cancer Research Updates 10 (October 25, 2021): 10–17. http://dx.doi.org/10.30683/1929-2279.2021.10.02.
Full textKOMIYA, Yoshiaki, Tadayoshi MATSUDA, Ikuhiro UTIDA, Syohei IWAMOTO, and Toshiaki KURASHIMA. "Investigation of therapeutic modality for cancer of the tongue." Japanese Journal of Oral & Maxillofacial Surgery 35, no. 6 (1989): 1617–27. http://dx.doi.org/10.5794/jjoms.35.1617.
Full textDagnelie, P. C., J. W. O. van den Berg, J. D. Bell, C. S. Foster, T. Rietveld, and G. R. Swart. "Fish oil: a new therapeutic modality in cancer cachexia?" Clinical Nutrition 12 (January 1993): 50. http://dx.doi.org/10.1016/0261-5614(93)90296-g.
Full textItoh, Kyogo, and Akira Yamada. "Personalized peptide vaccines: A new therapeutic modality for cancer." Cancer Science 97, no. 10 (October 2006): 970–76. http://dx.doi.org/10.1111/j.1349-7006.2006.00272.x.
Full textTordiglione, Michele, Maurizio Kalli, Vittorio Vavassori, and Roberto Luraghi. "Combined Modality Treatment for Esophageal Cancer." Tumori Journal 84, no. 2 (March 1998): 252–58. http://dx.doi.org/10.1177/030089169808400226.
Full textVandghanooni, Somayeh, Morteza Eskandani, Jaleh Barar, and Yadollah Omidi. "Aptamedicine: a new treatment modality in personalized cancer therapy." BioImpacts 9, no. 2 (November 30, 2018): 66–69. http://dx.doi.org/10.15171/bi.2019.09.
Full textLee, Y., J. Jung, G. Hwang, H. Park, and Y. Im. "Multimodal therapeutic approach in anaplastic thyroid cancer." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 15533. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.15533.
Full textStorozynsky, Quinn, and Mary M. Hitt. "The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer." International Journal of Molecular Sciences 21, no. 22 (November 23, 2020): 8877. http://dx.doi.org/10.3390/ijms21228877.
Full textChen, Lili, Xiaohong Wang, Fangling Ji, Yongming Bao, Jingyun Wang, Xianwu Wang, Lianying Guo, and Yachen Li. "New bifunctional-pullulan-based micelles with good biocompatibility for efficient co-delivery of cancer-suppressing p53 gene and doxorubicin to cancer cells." RSC Advances 5, no. 115 (2015): 94719–31. http://dx.doi.org/10.1039/c5ra17139c.
Full textLi, Mingjing, Fan Yu, Chao Yao, Peng George Wang, Yonghui Liu, and Wei Zhao. "Synthetic and immunological studies on trimeric MUC1 immunodominant motif antigen-based anti-cancer vaccine candidates." Organic & Biomolecular Chemistry 16, no. 6 (2018): 993–99. http://dx.doi.org/10.1039/c7ob02976d.
Full textZhang, Wei, Yang Zang, Yanli Lu, Jinhui Han, Qingyun Xiong, and Jinping Xiong. "Photothermal Effect and Multi-Modality Imaging of Up-Conversion Nanomaterial Doped with Gold Nanoparticles." International Journal of Molecular Sciences 23, no. 3 (January 26, 2022): 1382. http://dx.doi.org/10.3390/ijms23031382.
Full textTalbot, Jean-Noël. "The clinical impact of [18F]-FDG Pet during the opening year of a Pet centre." Brazilian Archives of Biology and Technology 45, spe (September 2002): 61–67. http://dx.doi.org/10.1590/s1516-89132002000500009.
Full textDing, Yi, Ziyi Song, Qian Liu, Shaohua Wei, Lin Zhou, Jiahong Zhou, and Jian Shen. "An enhanced chemotherapeutic effect facilitated by sonication of MSN." Dalton Transactions 46, no. 35 (2017): 11875–83. http://dx.doi.org/10.1039/c7dt02600e.
Full textDatta, Niloy R., Bharati M. Jain, Zatin Mathi, Sneha Datta, Satyendra Johari, Ashok R. Singh, Pallavi Kalbande, Pournima Kale, Vitaladevuni Shivkumar, and Stephan Bodis. "Hyperthermia: A Potential Game-Changer in the Management of Cancers in Low-Middle-Income Group Countries." Cancers 14, no. 2 (January 9, 2022): 315. http://dx.doi.org/10.3390/cancers14020315.
Full textSingh, Nathan. "Modified T cells as therapeutic agents." Hematology 2021, no. 1 (December 10, 2021): 296–302. http://dx.doi.org/10.1182/hematology.2021000262.
Full textPort, Jeffrey L., Mohamed K. Kamel, and Nasser K. Altorki. "Surgery is the Optimum Local Therapeutic Modality for Second Primary Lung Cancer." Seminars in Thoracic and Cardiovascular Surgery 28, no. 1 (2016): 201–2. http://dx.doi.org/10.1053/j.semtcvs.2016.04.013.
Full textElOjeimy, S., J. C. McKillop, A. M. El-Zawahry, D. H. Holman, X. Liu, D. A. Schwartz, T. A. Day, J.-Y. Dong, and J. S. Norris. "FasL gene therapy: a new therapeutic modality for head and neck cancer." Cancer Gene Therapy 13, no. 8 (March 17, 2006): 739–45. http://dx.doi.org/10.1038/sj.cgt.7700951.
Full textHeys, S. D., D. B. Gough, L. Khan, and O. Ermin. "Nutritional pharmacology and malignant disease: A therapeutic modality in patients with cancer." British Journal of Surgery 83, no. 5 (May 1996): 608–19. http://dx.doi.org/10.1002/bjs.1800830508.
Full textStoiber, Stefan, Bruno L. Cadilha, Mohamed-Reda Benmebarek, Stefanie Lesch, Stefan Endres, and Sebastian Kobold. "Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy." Cells 8, no. 5 (May 17, 2019): 472. http://dx.doi.org/10.3390/cells8050472.
Full textGupta, Archana A., Supriya Kheur, A. Thirumal Raj, Ravindra V. Badhe, and Ramesh R. Bhonde. "Reviewing the potential use of scaffold-mediated localized chemotherapy in oncology." Forum of Clinical Oncology 11, no. 3 (December 1, 2020): 23–27. http://dx.doi.org/10.2478/fco-2019-0022.
Full textTruong, Cao-Sang, and So Young Yoo. "Oncolytic Vaccinia Virus in Lung Cancer Vaccines." Vaccines 10, no. 2 (February 4, 2022): 240. http://dx.doi.org/10.3390/vaccines10020240.
Full textDai, Chen, Ruizhi Hu, Chunmei Wang, Zhuang Liu, Shengjian Zhang, Luodan Yu, Yu Chen, and Bo Zhang. "Defect engineering of 2D BiOCl nanosheets for photonic tumor ablation." Nanoscale Horizons 5, no. 5 (2020): 857–68. http://dx.doi.org/10.1039/c9nh00707e.
Full textZhang, Wei, Yanli Lu, Yang Zang, Jinhui Han, Qingyun Xiong, and Jinping Xiong. "Photodynamic Therapy and Multi-Modality Imaging of Up-Conversion Nanomaterial Doped with AuNPs." International Journal of Molecular Sciences 23, no. 3 (January 22, 2022): 1227. http://dx.doi.org/10.3390/ijms23031227.
Full textLiu, Wei, Binbin Yang, Lu Yang, Jasmine Kaur, Calvin Jessop, Rushdi Fadhil, David Good, et al. "Therapeutic Effects of Ten Commonly Used Chinese Herbs and Their Bioactive Compounds on Cancers." Evidence-Based Complementary and Alternative Medicine 2019 (September 15, 2019): 1–10. http://dx.doi.org/10.1155/2019/6057837.
Full textFatima, Syeda Warisul, Khalid Imtiyaz, Mohammad M. Alam Rizvi, and Sunil K. Khare. "Microbial transglutaminase nanoflowers as an alternative nanomedicine for breast cancer theranostics." RSC Advances 11, no. 55 (2021): 34613–30. http://dx.doi.org/10.1039/d1ra04513j.
Full textKhan, Maliha, Anum Wasim, Aibek E. Mirrakhimov, Blaithin A. McMahon, Daniel P. Judge, Linda C. Chu, Ashtami Banavali, and Amer M. Zeidan. "Case Report of a Patient with Left Ventricular Assistance Device Undergoing Chemotherapy for a New Diagnosis of Lung Cancer." Case Reports in Oncological Medicine 2015 (2015): 1–3. http://dx.doi.org/10.1155/2015/163727.
Full textYamamoto, Masato, and David T. Curiel. "Cancer Gene Therapy." Technology in Cancer Research & Treatment 4, no. 4 (August 2005): 315–30. http://dx.doi.org/10.1177/153303460500400402.
Full textDai, Xiaofeng, Erik W. Thompson, and Kostya (Ken) Ostrikov. "Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers." Biomolecules 12, no. 12 (December 15, 2022): 1880. http://dx.doi.org/10.3390/biom12121880.
Full textYu, Qianqian, Jing Sun, Xufeng Zhu, Lin Qiu, Mengmeng Xu, Sirun Liu, Jianming Ouyang, and Jie Liu. "Mesoporous titanium dioxide nanocarrier with magnetic-targeting and high loading efficiency for dual-modal imaging and photodynamic therapy." Journal of Materials Chemistry B 5, no. 30 (2017): 6081–96. http://dx.doi.org/10.1039/c7tb01035d.
Full textMoll, Ute M., and Alex Zaika. "Disrupting the p53-mdm2 interaction as a potential therapeutic modality." Drug Resistance Updates 3, no. 4 (August 2000): 217–21. http://dx.doi.org/10.1054/drup.2000.0160.
Full textJuarranz, Ángeles, Yolanda Gilaberte, and Salvador González. "Photodynamic Therapy (PDT) in Oncology." Cancers 12, no. 11 (November 12, 2020): 3341. http://dx.doi.org/10.3390/cancers12113341.
Full textGuikema, Jeroen E., Martine Amiot, and Eric Eldering. "Exploiting the pro-apoptotic function of NOXA as a therapeutic modality in cancer." Expert Opinion on Therapeutic Targets 21, no. 8 (July 18, 2017): 767–79. http://dx.doi.org/10.1080/14728222.2017.1349754.
Full textYoshii, T., S. Tamai, O. Motohashi, K. Yonemitsu, A. Kiyohashi, S. Takagi, N. Nakayama, and Y. Murata. "Evaluation of significance of endoscopic mucosal resection (EMR) in early esophageal cancer." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 4088. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.4088.
Full textSekido, Yoshitaka. "Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma." Cancers 10, no. 4 (March 22, 2018): 90. http://dx.doi.org/10.3390/cancers10040090.
Full textTeramae, Fumio, Tomohiro Makino, Shintaro Sengoku, Yeongjoo Lim, Takashi Natori, and Kota Kodama. "Research on Pharmaceutical Product Life Cycle Patterns for Sustainable Growth." Sustainability 12, no. 21 (October 27, 2020): 8938. http://dx.doi.org/10.3390/su12218938.
Full textEnomoto, Keisuke, Xuguang Zhu, Sunmi Park, Li Zhao, Yuelin J. Zhu, Mark C. Willingham, Jun Qi, John A. Copland, Paul Meltzer, and Sheue-yann Cheng. "Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer." Journal of Clinical Endocrinology & Metabolism 102, no. 7 (March 28, 2017): 2268–80. http://dx.doi.org/10.1210/jc.2016-3771.
Full textDavis, Mark E., Zhuo Chen, and Dong M. Shin. "Nanoparticle therapeutics: an emerging treatment modality for cancer." Nature Reviews Drug Discovery 7, no. 9 (September 2008): 771–82. http://dx.doi.org/10.1038/nrd2614.
Full textSrinivas, Sandy. "Management of Metastatic Castration-Resistant Prostate Cancer." Journal of the National Comprehensive Cancer Network 19, no. 5.5 (May 2021): 614–16. http://dx.doi.org/10.6004/jnccn.2021.5003.
Full textHasegawa, Bruce H., Kenneth H. Wong, Koji Iwata, William C. Barber, Andrew B. Hwang, Anne E. Sakdinawat, Mohan Ramaswamy, David C. Price, and Randall A. Hawkins. "Dual-Modality Imaging of Cancer with SPECT/CT." Technology in Cancer Research & Treatment 1, no. 6 (December 2002): 449–58. http://dx.doi.org/10.1177/153303460200100605.
Full textLittle, Richard F., and Kieron Dunleavy. "Update on the treatment of HIV-associated hematologic malignancies." Hematology 2013, no. 1 (December 6, 2013): 382–88. http://dx.doi.org/10.1182/asheducation-2013.1.382.
Full textAtwa, Sara M., Margarete Odenthal, and Hend M. El Tayebi. "Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma." Cancers 13, no. 17 (August 27, 2021): 4343. http://dx.doi.org/10.3390/cancers13174343.
Full textBrizel, David. "Management of Human Papillomavirus–Induced Oropharynx Cancer." American Society of Clinical Oncology Educational Book, no. 32 (June 2012): 368–71. http://dx.doi.org/10.14694/edbook_am.2012.32.57.
Full textMurthy, Vedang, Sayan Kundu, Tanweer Shahid, Ashwini Budrukkar, Tejpal Gupta, Sarbani Ghosh Laskar, and Jaiprakash Agarwal. "Postoperative Radiotherapy in Head and Neck Cancer." An International Journal of Otorhinolaryngology Clinics 2, no. 1 (2010): 43–51. http://dx.doi.org/10.5005/jp-journals-10003-1016.
Full textDuda, Dan G., Rakesh K. Jain, and Christopher G. Willett. "Antiangiogenics: The Potential Role of Integrating This Novel Treatment Modality With Chemoradiation for Solid Cancers." Journal of Clinical Oncology 25, no. 26 (September 10, 2007): 4033–42. http://dx.doi.org/10.1200/jco.2007.11.3985.
Full textTormoen, Garth W., Marka R. Crittenden, and Michael J. Gough. "The TAM family as a therapeutic target in combination with radiation therapy." Emerging Topics in Life Sciences 1, no. 5 (December 12, 2017): 493–500. http://dx.doi.org/10.1042/etls20170066.
Full textHe, Xinjia, Qiaqia He, Lihua Wang, and Xiaofei He. "New Researches about Combinatorial Therapeutic Regimen on Cancer Treatment." Current Cancer Therapy Reviews 16, no. 2 (June 9, 2020): 97–109. http://dx.doi.org/10.2174/1573394715666190906125014.
Full textCha, Edward, and Lawrence Fong. "Immunotherapy for Prostate Cancer: Biology and Therapeutic Approaches." Journal of Clinical Oncology 29, no. 27 (September 20, 2011): 3677–85. http://dx.doi.org/10.1200/jco.2010.34.5025.
Full textHuang, Gan, and Shu-Ting Pan. "ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer." Oxidative Medicine and Cellular Longevity 2020 (July 22, 2020): 1–30. http://dx.doi.org/10.1155/2020/5047987.
Full textZhou, Gang, and Hyam Levitsky. "Towards Curative Cancer Immunotherapy: Overcoming Posttherapy Tumor Escape." Clinical and Developmental Immunology 2012 (2012): 1–12. http://dx.doi.org/10.1155/2012/124187.
Full textBhavar, Prashant Kashinath, Uday Kumar Surampudi, Partha Pratim Sarma, Satish Katike, and Adilakshmi Gandham. "Abstract A037: PROTACs as emergent treatment modality of metastatic prostate cancer. [R." Cancer Research 83, no. 2_Supplement_2 (January 15, 2023): A037. http://dx.doi.org/10.1158/1538-7445.metastasis22-a037.
Full text